brain Logo
DE
  • 61

    We draw inspiration from the biodiversity of nature: from microorganisms, their specific abilities and the enzymes that support these abilities.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2024
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2025
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • Social Responsibility
    • Environment
    • Corporate Management
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

27.09.2022
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
Corporate
Show Article
26.09.2022
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
Corporate
Show Article
29.08.2022
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Finance
Show Article
20.06.2022
BRAIN Biotech publishes first ESG and Sustainability Report
Corporate
Show Article
30.05.2022
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting
Finance
Show Article
30.05.2022
Prof. Dr Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Corporate
Show Article
04.04.2022
Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)
Technology
Show Article
09.03.2022
Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG
Corporate Finance
Show Article
23.02.2022
BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting
Finance
Show Article
  • 1
  • 5
  • 6
  • 7
  • 8
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2025 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings